ELECTROMED INC

NYSE: ELMD (Electromed, Inc.)

Last update: 10 Aug, 3:16PM

18.64

-0.01 (-0.05%)

Previous Close 18.65
Open 18.81
Volume 23,958
Avg. Volume (3M) 82,782
Market Cap 156,317,264
Price / Earnings (TTM) 23.59
Price / Earnings (Forward) 23.75
Price / Sales 3.44
Price / Book 4.78
52 Weeks Range
13.74 (-26%) — 35.56 (90%)
Earnings Date 26 Aug 2025
Profit Margin 11.65%
Operating Margin (TTM) 13.64%
Diluted EPS (TTM) 0.790
Quarterly Revenue Growth (YOY) 13.10%
Quarterly Earnings Growth (YOY) 26.70%
Total Debt/Equity (MRQ) 0.25%
Current Ratio (MRQ) 5.19
Operating Cash Flow (TTM) 12.02 M
Levered Free Cash Flow (TTM) 12.07 M
Return on Assets (TTM) 11.04%
Return on Equity (TTM) 16.56%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Bearish Bearish
Medical Devices (Global) Bearish Bearish
Stock Electromed, Inc. Mixed -

AIStockmoo Score

0.9
Analyst Consensus -2.0
Insider Activity NA
Price Volatility 4.5
Technical Moving Averages -1.0
Technical Oscillators 2.0
Average 0.88

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
ELMD 156 M - 23.59 4.78
SENS 375 M - - 3.96
SI 300 M - - -
CATX 250 M - - 1.01
XTNT 96 M - - 1.72
ASXC 92 M - - 7.09

Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care and institutional markets for patients with bronchiectasis, cystic fibrosis, and neuromuscular diseases. It markets its products primarily to physicians and health care providers, as well as directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

Sector Healthcare
Industry Medical Devices
% Held by Insiders 20.96%
% Held by Institutions 51.63%

No data within this time range.

No data within this time range.

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria